High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Mayo Clinic
Garden State Cancer Center at the Center for Molecular Medicine and Immunology